Skip to main content

Table 1 METTL14 expression associated with clinical pathological variables (logistic regression)

From: Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma

Variable

METTL14 mRNA expression

OR

95% CI

p

Age(year)

 > 65 vs. ≤ 65

0.769

0.532–1.110

0.161

Gender

 Female vs. male

0.573

0.395–0.827

0.003

Race

 African vs. White

0.923

0.198- 4.300

0.916

 Asian vs. White

0.915

0.507–1.644

0.766

Grade

 G3–4 vs. G1–2

0.338

0.235–0.484

0.000

Stage

 Stage III & IV VS Stage I & II

0.310

0.213–0.449

0.000

T stage

 T3–4 vs. T1–2

0.318

0.216–0.464

0.000

N stage

 N1-X vs. NO

0.867

0.611–1.229

0.423

M stage

 M1-X vs. M0

0.467

0.297–0.725

0.000